• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Limited influence of dutasteride on individual prostate-specific antigen variability in men with clinical benign prostatic hyperplasia.

作者信息

Takeshita Hideki, Kawakami Satoru, Kagawa Makoto, Yano Akihiro, Okada Yohei, Morozumi Makoto

机构信息

Department of Urology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.

Department of Urology, Harada Hospital, Iruma, Saitama, Japan.

出版信息

Int J Urol. 2018 Jun;25(6):633-634. doi: 10.1111/iju.13557. Epub 2018 Apr 25.

DOI:10.1111/iju.13557
PMID:29693288
Abstract
摘要

相似文献

1
Limited influence of dutasteride on individual prostate-specific antigen variability in men with clinical benign prostatic hyperplasia.
Int J Urol. 2018 Jun;25(6):633-634. doi: 10.1111/iju.13557. Epub 2018 Apr 25.
2
Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.度他雄胺可缩小前列腺体积并降低前列腺特异性抗原水平，适用于接受睾酮替代疗法的老年性腺功能减退伴良性前列腺增生症患者。
J Urol. 2011 Jul;186(1):191-7. doi: 10.1016/j.juro.2011.03.026. Epub 2011 May 14.
3
Influence of dutasteride treatment on serum hormone levels and aging male symptoms in patients with benign prostatic enlargement.度他雄胺治疗对良性前列腺增生患者血清激素水平及男性衰老症状的影响。
Int J Urol. 2018 Jan;25(1):70-74. doi: 10.1111/iju.13470. Epub 2017 Oct 3.
4
Evaluation of sexual function after dutasteride treatment in patients with once-negative prostate biopsy and benign prostate hyperplasia.评估经度他雄胺治疗前列腺活检阴性和良性前列腺增生患者的性功能。
Urologia. 2023 May;90(2):295-300. doi: 10.1177/03915603231163201. Epub 2023 Mar 29.
5
[Specific antigen prostatic changes during treatment with finasteride or dutasteride for benign prostatic hyperplasia].非那雄胺或度他雄胺治疗良性前列腺增生期间的前列腺特异性抗原变化
Minerva Urol Nefrol. 2013 Sep;65(3):211-6.
6
[Considerations about the value of prostate specific antigen in patients treated with 5-α reductase].
Semergen. 2013 Mar;39(2):118. doi: 10.1016/j.semerg.2012.07.003. Epub 2012 Sep 13.
7
The effect of dutasteride on microscopic and macroscopic changes of testosterone replacement treatment on prostate tissue.度他雄胺对睾酮替代治疗前列腺组织的微观和宏观变化的影响。
Andrologia. 2018 Dec;50(10):e13110. doi: 10.1111/and.13110. Epub 2018 Jul 19.
8
Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia.度他雄胺治疗良性前列腺增生症男性患者四年的疗效和安全性。
Urology. 2004 Apr;63(4):709-15. doi: 10.1016/j.urology.2004.01.001.
9
Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction.度他雄胺对下尿路症状的影响：基于睾酮/双氢睾酮水平变化和前列腺总体积缩小的前瞻性分析。
Aging Male. 2016 Jun;19(2):128-33. doi: 10.3109/13685538.2016.1145205. Epub 2016 Feb 18.
10
Percent decrease of serum prostate-specific antigen after dutasteride administration is equivalent in men with clinical benign prostatic hyperplasia having baseline prostate-specific antigen >10 ng/mL and those having baseline prostate-specific antigen 2.5-10 ng/mL.度他雄胺治疗后，基线前列腺特异性抗原>10 ng/mL的临床良性前列腺增生男性与基线前列腺特异性抗原为2.5 - 10 ng/mL的男性相比，血清前列腺特异性抗原的降低百分比相当。
Int J Urol. 2017 Mar;24(3):238-239. doi: 10.1111/iju.13284. Epub 2017 Feb 16.